Table 1.
Characteristics of Interview Sample (n = 33)
| Demographics | n (%) |
|---|---|
| Ethnicity (n = 33) | |
| African American | 24 (73) |
| White | 6 (18) |
| Other (Hispanic, Asian) | 3 (9) |
| Age (n = 33) | |
| Average age [range] | 55 [33 to 77] |
| 30 to 39 | 4 (12) |
| 40 to 49 | 5 (15) |
| 50 to 59 | 12 (36) |
| ≥60 | 12 (36) |
| Education (y, n = 30) | |
| < 12 | 9 (30) |
| 12 | 9 (30) |
| 13 to 15 | 9 (30) |
| 16+ | 3 (10) |
| Marital status (n = 31) | |
| Divorced/widowed | 12 (39) |
| Married | 10 (32) |
| Single | 9 (29) |
| Employment status (n = 32) | |
| Employed | 13 (41) |
| Retired | 8 (25) |
| Not employed | 7 (22) |
| Disability | 4 (12) |
| Religious affiliation (n = 24) | |
| Baptist | 13 (54) |
| Catholic | 5 (21) |
| Nondenomination/other protestant | 4 (17) |
| Jewish | 1 (4) |
| Muslim | 1 (4) |
| Health variables | |
| High-risk clinic (n = 33) | |
| Return patients | 25 (76) |
| New patients | 8 (24) |
| Referral source (n = 33) | |
| Physician referral | 32 (97) |
| Self-referred | 1 (3) |
| Breast cancer risk* | |
| Gail 5 y† (n = 32) | |
| Average (range) | 2.7 (0.8 to 7.0) |
| ≥1.67% | 18 (56) |
| < 1.67% | 14 (44) |
| BRCA carrier‡ (n = 32) | |
| High risk | 11 (34) |
| Moderate/high risk | 8 (25) |
| Moderate risk | 6 (19) |
| Low/moderate risk | 5 (12) |
| Low risk | 2 (6) |
| “Moderate to high risk”§ | 29 (88) |
| Comorbidities∥ (n = 33) | |
| 0 | 6 (18) |
| 1 | 10 (30) |
| 2 | 8 (24) |
| 2 | 9 (27) |
*
As documented in the patient's medical record
†
A Gail 5-year risk value of 1.67% or above is considered appropriate for prescribing tamoxifen for risk reduction.37
‡
BRCA carrier risk is a physician's assessment of hereditary cancer risk based on consideration of the patient's family cancer history
§
Refers to patients who had an elevated Gail risk or were categorized as having moderate, moderate/high, or high BRCA carrier risk
∥
Self-reported health conditions currently under treatment or assessment by a physician. Includes: diabetes, hypertension, lupus, arthritis, heart problems, emphysema/asthma/COPD, depression, and menopausal symptoms